Social Media Use of Psoriasis Vulgaris Patients: Multicenter, Survey Work
NCT ID: NCT04207242
Last Updated: 2021-02-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1520 participants
OBSERVATIONAL
2020-01-01
2020-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Use of Alternative Therapy in Psoriasis Vulgaris Patients
NCT04207216
Comparison of Scalp Microbiota of the Psoriasis and Seborrheic Dermatitis Patients
NCT03807453
A Survey on the Role and Benefits of Online Social Networks on Filipino Patients With Psoriasis
NCT01465061
Association Between Biologic Therapy and Demodex Density in Psoriasis Patients: A Comparative Study
NCT05954572
Metabolic Syndrome in Psoriasis and Psoriatic Arthritis and Correlation With Serum Omentin and Visfatin Levels
NCT03932110
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
ECOLOGIC_OR_COMMUNITY
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Istanbul Medeniyet University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Melek Aslan Kayıran
Specialist Dermatologist Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Melek Aslan Kayıran
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IstanbulMU5
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.